ProfileGDS5678 / 1460663_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 11.774831
GSM967853U87-EV human glioblastoma xenograft - Control 21.76771
GSM967854U87-EV human glioblastoma xenograft - Control 31.768191
GSM967855U87-EV human glioblastoma xenograft - Control 41.72221
GSM967856U87-EV human glioblastoma xenograft - Control 51.7491
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 11.80951
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 21.761421
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 31.750051
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 41.747491
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 11.758381
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 21.754281
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 31.752541
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.761831
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.758471